Lv5
1090 积分 2025-03-27 加入
Cell therapy for liver disorders: past, present and future
6天前
已完结
Improvement in aged liver regeneration using cell transplantation with chemically induced liver progenitors
13天前
已完结
Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model
13天前
已完结
An extracorporeal bioartificial liver embedded with 3D-layered human liver progenitor-like cells relieves acute liver failure in pigs
13天前
已完结
Reversible transition between hepatocytes and liver progenitors for in vitro hepatocyte expansion
13天前
已完结
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
22天前
已完结
Efficacy and Safety of Mesenchymal Stem Cell Therapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
23天前
已完结
Therapeutic Efficacy of Mesenchymal Stem Cells (MSCs) on Alzheimer’s Disease: Review of Clinical Results
23天前
已完结
Tumor Serosal Invasion in Perihilar Cholangiocarcinoma
26天前
已完结
Indocyanine Green Fluorescent Cholangiography During Laparoscopic Cholecystectomy and Bile Duct Injury
26天前
已完结
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
6个月前
已采纳
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
6个月前
已采纳
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
6个月前
已驳回
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
6个月前
已采纳
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation
6个月前
已采纳
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
6个月前
已采纳
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
6个月前
已撤回
皖公网安备34019202002308
